FibroBiologics, Inc. (FBLG)
0.95
-0.07
(-6.86%)
USD |
NASDAQ |
Oct 23, 16:00
0.9643
+0.01
(+1.51%)
Pre-Market: 20:00
FibroBiologics Net Income (Quarterly) : -4.117M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.117M |
| March 31, 2026 | -5.00M |
| December 31, 2025 | -3.244M |
| September 30, 2025 | -5.778M |
| June 30, 2025 | -4.658M |
| March 31, 2025 | -4.966M |
| December 31, 2024 | -3.099M |
| September 30, 2024 | -0.50M |
| Date | Value |
|---|---|
| June 30, 2024 | 0.898M |
| March 31, 2024 | -8.46M |
| December 31, 2023 | -9.717M |
| September 30, 2023 | -2.192M |
| June 30, 2023 | -2.161M |
| March 31, 2023 | -2.415M |
| December 31, 2022 | -1.524M |
| September 30, 2022 | -1.562M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.117M |
| EPS Diluted (Quarterly) | -0.6564 |
| Enterprise Value | 3.724M |
| Earnings Yield | -593.7% |
| Normalized Earnings Yield | -556.25 |